AC Immune SA 1 year target
What is the 1 year target of AC Immune SA?
The 1 year target of AC Immune SA is $12 +275.94%
What is the definition of 1 year target?
1 year target is a predicted stock price a year from now.
= average of analyst price targets
One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.
1 year target of companies in the Health Care sector on NASDAQ compared to AC Immune SA
What does AC Immune SA do?
ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor
Companies with 1 year target similar to AC Immune SA
- First High-School Education Co has 1 year target of $2 +480.65%
- U.S. Xpress Enterprises Inc has 1 year target of $11 +79.15%
- Yuexiu Property has 1 year target of HKD$13 +208.83%
- Chindata Ltd has 1 year target of $2 -80.71%
- New York Community Bancorp has 1 year target of $11 +10.50%
- Alvopetro has 1 year target of CAD$15 +186.64%
- AC Immune SA has 1 year target of $12 +275.94%
- Euronav NV has 1 year target of $11 -32.07%
- Calfrac Well Services has 1 year target of CAD$11 +183.38%
- Investors Bancorp Inc has 1 year target of $11 -20.12%
- Calithera Biosciences Inc has 1 year target of $11 +22,100.00%
- CRCAM Paris & Ile de France has 1 year target of €11 -80.99%
- CNH Industrial NV has 1 year target of $11 -2.97%